nipradilol has been researched along with Chromosomal Translocation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, A; Ito, S; Kaneko, S; Matsumura, M; Miyake, M; Nambu, R; Okuda-Ashitaka, E; Okumura, T; Taomoto, M; Unezaki, S; Yamazaki, Y | 1 |
1 other study(ies) available for nipradilol and Chromosomal Translocation
Article | Year |
---|---|
Cytoprotection by nipradilol, an anti-glaucomatous agent, via down-regulation of apoptosis related gene expression and activation of NF-kappaB.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Carrier Proteins; Caspase 9; Caspases; Down-Regulation; Gene Expression Regulation; Glaucoma; Mitochondrial Proteins; NF-kappa B; PC12 Cells; Polymerase Chain Reaction; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Translocation, Genetic | 2005 |